Loewen Andrea
- SEC CIK
- 0001591100
No open-market purchases or sales filed in the past year.
Current role at each company
- RETA Reata Pharmaceuticals IncSVP, Global Regulatory Affairsas of Sep 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Loewen Andrea as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2023 (view filing) | Sep 14 | 4 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −3.17K | $172.03 | −$546.2K | −10.1%28.4K after | |
| May 16, 2023 (view filing) | May 12-16 | 4 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −7.17K | $86.01 | −$616.3K | −18.5%31.6K after | 3 lots |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −19.0K | $83.43 | −$1.59M | −32.9%38.8K after | 2 lots |
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Loewen AndreaSVP, Global Regulatory Affairs | SSaleClass A common stock | −1.82K | $88.08 | −$160.2K | −4.1%42.8K after | 2 lots |